Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ABS Global is a world-leading provider of bovine genetics, reproduction services, and technologies, serving the dairy and beef industries. As a subsidiary of Genus plc, the company utilizes advanced genomic selection and sexing technologies to help producers improve the productivity and sustainability of their herds. Their flagship offerings include Sexcel sexed semen and the Genetic Management System (GMS), which leverage data-driven insights to optimize breeding outcomes. ABS Global operates across more than 70 countries, maintaining a significant presence in the global agricultural biotechnology sector. The company is also a pioneer in the application of in vitro fertilization (IVF) and other advanced reproductive techniques in livestock.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ABS Global.